Evidence map›Paper›PMID 27435737›Full record

ArticleBMC immunology2016

Cryptic protein-protein interaction motifs in the cytoplasmic domain of MHCI proteins.

Karla K Frietze, Adlai L Pappy, Jack W Melson, Emily E O'Driscoll, Carolyn M Tyler, David H Perlman, Lisa M Boulanger

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Immunopeptidome Landscape DuringInternational journal of molecular sciences · 2025
    Article
  3. Open MHC Class I Conformers: A Look through the Looking Glass.International journal of molecular sciences · 2021
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Karla K FrietzeDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Adlai L PappyDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Jack W MelsonDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Emily E O'DriscollDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Carolyn M TylerDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
David H PerlmanDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Lisa M BoulangerDepartment of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA. lboulang@princeton.edu.
Princeton University · US

Funding

NRSA Training Grant in Quantitative NeuroscienceT32MH065214 · NIMH · PRINCETON UNIVERSITY · PI Nathaniel Douglass Daw, KENNETH A NORMAN · 2002 to 2026
$7.9M
NIMH NIH HHS T32 MH065214
6 · The paper itself

Abstract

backgroundMajor histocompatibility complex class I (MHCI) proteins present antigenic peptides for immune surveillance and play critical roles in nervous system development and plasticity. Most MHCI are transmembrane proteins. The extracellular domain of MHCI interacts with immunoreceptors, peptides, and co-receptors to mediate immune signaling. While the cytoplasmic domain also plays important roles in endocytic trafficking, cross-presentation of extracellularly derived antigens, and CTL priming, the molecular mediators of cytoplasmic signaling by MHCI remain largely unknown.

resultsHere we show that the cytoplasmic domain of MHCI contains putative protein-protein interaction domains known as PDZ (PSD95/disc large/zonula occludens-1) ligands. PDZ ligands are motifs that bind to PDZ domains to organize and mediate signaling at cell-cell contacts. PDZ ligands are short, degenerate motifs, and are therefore difficult to identify via sequence homology alone, but several lines of evidence suggest that putative PDZ ligand motifs in MHCI are under positive selective pressure. Putative PDZ ligands are found in all of the 99 MHCI proteins examined from diverse species, and are enriched in the cytoplasmic domain, where PDZ interactions occur. Both the position of the PDZ ligand and the class of ligand motif are conserved across species, as well as among genes within a species. Non-synonymous substitutions, when they occur, frequently preserve the motif. Of the many specific possible PDZ ligand motifs, a handful are strikingly and selectively overrepresented in MHCI's cytoplasmic domain, but not elsewhere in the same proteins. Putative PDZ ligands in MHCI encompass conserved serine and tyrosine residues that are targets of phosphorylation, a post-translational modification that can regulate PDZ interactions. Finally, proof-of-principle in vitro interaction assays demonstrate that the cytoplasmic domains of particular MHCI proteins can bind directly and specifically to PDZ1 and PDZ4&5 of MAGI-1, and identify a conserved PDZ ligand motif in the classical MHCI H2-K that is required for this interaction.

conclusionsThese results identify cryptic protein interaction motifs in the cytoplasmic domain of MHCI. In so doing, they suggest that the cytoplasmic domain of MHCI could participate in previously unsuspected PDZ mediated protein-protein interactions at neuronal as well as immunological synapses.

Indexed as

Amino Acid MotifsAnimalsAntigen PresentationCytoplasmH-2 AntigensHLA AntigensHumansImmunological SynapsesImmunologic SurveillanceMiceNervous SystemPDZ DomainsPhosphorylationProtein Interaction Domains and MotifsSequence Analysis, ProteinSerineH-2 AntigensH-2Kb protein, mouseHLA AntigensSerineTyrosineBrainCytoplasmicImmuneMHC class IMHCIPDZPDZ ligandScaffoldingSynapse

Identifiers

PMID27435737
PMCPMC4950430
OpenAlexW2476356007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.